These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8787948)
1. Clinical pharmacokinetics of zopiclone. Fernandez C; Martin C; Gimenez F; Farinotti R Clin Pharmacokinet; 1995 Dec; 29(6):431-41. PubMed ID: 8787948 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. Fernandez C; Maradeix V; Gimenez F; Thuillier A; Farinotti R Drug Metab Dispos; 1993; 21(6):1125-8. PubMed ID: 7905394 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective distribution and stereoconversion of zopiclone enantiomers in plasma and brain tissues in rats. Fernandez C; Alet P; Davrinche C; Adrien J; Thuillier A; Farinotti R; Gimenez F J Pharm Pharmacol; 2002 Mar; 54(3):335-40. PubMed ID: 11902799 [TBL] [Abstract][Full Text] [Related]
4. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. Gaillot J; Le Roux Y; Houghton GW; Dreyfus JF Sleep; 1987; 10 Suppl 1():7-21. PubMed ID: 3438645 [TBL] [Abstract][Full Text] [Related]
5. Enantioselective determination of zopiclone and its metabolites in urine by capillary electrophoresis. Hempel G; Blaschke G J Chromatogr B Biomed Appl; 1996 Jan; 675(1):139-46. PubMed ID: 8634755 [TBL] [Abstract][Full Text] [Related]
6. Validation of a high-performance liquid chromatographic method for the enantiospecific quantitation of zopiclone in plasma. Gebauer MG; Alderman CP Biomed Chromatogr; 2002 Jun; 16(4):241-6. PubMed ID: 11933023 [TBL] [Abstract][Full Text] [Related]
7. The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone. Aranko K; Luurila H; Backman JT; Neuvonen PJ; Olkkola KT Br J Clin Pharmacol; 1994 Oct; 38(4):363-7. PubMed ID: 7833227 [TBL] [Abstract][Full Text] [Related]
8. Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis. Marc-Aurele J; Caille G; Bourgoin J Sleep; 1987; 10 Suppl 1():22-6. PubMed ID: 3438644 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers. Caille G; du Souich P; Spenard J; Lacasse Y; Vezina M Biopharm Drug Dispos; 1984; 5(2):117-25. PubMed ID: 6743780 [TBL] [Abstract][Full Text] [Related]
10. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure. Viron B; De Meyer M; Le Liboux A; Frydman A; Maillard F; Mignon F; Gaillot J Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():95-104. PubMed ID: 2387982 [TBL] [Abstract][Full Text] [Related]
11. Zopiclone concentrations in oral fluid and blood after, administration of therapeutic doses of zopiclone. Hjelmeland K; Gustavsen I; Øiestad EL; Øiestad ÅML; Høiseth G; Mørland J Forensic Sci Int; 2017 Sep; 278():177-183. PubMed ID: 28735217 [TBL] [Abstract][Full Text] [Related]
12. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Najib J Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462 [TBL] [Abstract][Full Text] [Related]
13. Distribution of zopiclone and main metabolites in hair following a single dose. Hansen SL; Johansen SS; Nielsen MKK; Nilsson G; Kronstrand R Forensic Sci Int; 2020 Jan; 306():110074. PubMed ID: 31809905 [TBL] [Abstract][Full Text] [Related]
14. Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection. Mannaert E; Tytgat J; Daenens P J Anal Toxicol; 1997; 21(3):208-12. PubMed ID: 9171204 [TBL] [Abstract][Full Text] [Related]
15. Enantioselective analysis of zopiclone and its metabolites in plasma by liquid chromatography/tandem mass spectrometry. Tonon MA; Jabor VA; Bonato PS Anal Bioanal Chem; 2011 Jul; 400(10):3517-25. PubMed ID: 21547427 [TBL] [Abstract][Full Text] [Related]
16. UHPLC-MS/MS and UHPLC-HRMS identification of zolpidem and zopiclone main urinary metabolites and method development for their toxicological determination. Strano Rossi S; Anzillotti L; Castrignanò E; Frison G; Zancanaro F; Chiarotti M Drug Test Anal; 2014 Mar; 6(3):226-33. PubMed ID: 23512850 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of zopiclone. Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377 [TBL] [Abstract][Full Text] [Related]
18. Determination of zopiclone enantiomers in plasma by liquid chromatography using a chiral cellulose carbamate column. Fernandez C; Baune B; Gimenez F; Thuillier A; Farinotti R J Chromatogr; 1991 Dec; 572(1-2):195-202. PubMed ID: 1818054 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem. Chouinard G; Lefko-Singh K; Teboul E Cell Mol Neurobiol; 1999 Aug; 19(4):533-52. PubMed ID: 10379424 [TBL] [Abstract][Full Text] [Related]
20. The excretion of zopiclone into breast milk. Matheson I; Sande HA; Gaillot J Br J Clin Pharmacol; 1990 Aug; 30(2):267-71. PubMed ID: 2206788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]